Cat. #160398
Cre Luciferase cell line
Cat. #: 160398
Unit size: 1x10^6 cells / vial
Availability: 10-12 weeks
Organism: Human
Disease: Diabetes
Model: Reporter
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Timothy Kieffer
Institute: The University of British Columbia
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Cre Luciferase cell line
- Research fields: Drug development
- Parental cell: HEK293
- Organism: Human
- Disease: Diabetes
- Model: Reporter
- Conditional: No
- Description: This is a control cell line that was developed alongside the GLP-1 receptor cell line (Catalog #160395), GIP receptor cell line (Catalog #160396), and Glucagon Receptor Cell line (Catalog #160397).
- Production details: HEK293 cells were transfected with pHTS-Cre plasmid. Cells were grown in HG-DMEM supplemented with 800 ug/mL hygromycin and geneticin.
Target Details
- Target: Cre luciferase
Handling
- Format: Frozen
- Growth medium: DMEM with 10% FBS, 100 IU/mL penicillin, 100 ug/mL streptomycin
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
